Senseonics Holdings Inc (NYSE: SENS) today announced an additional demonstration of PROMISE Study facts assessing the next generation Eversense CGM System at the American Diabetes Association Simulated 81st Annual Technical Meetings. Data presented by Satish Garg MD The data assessing the security and correctness of the next generation Eversense system […]